Top in endocrinology: Rise in hip fractures; long-term weight loss
Click Here to Manage Email Alerts
Data from 20 health care databases in 19 countries project there will be a substantial increase in hip fracture incidence rates as the global population ages.
The data also showed a sex disparity in hip fracture treatment, with a lower treatment rate for men than women across countries. It was the top story in endocrinology last week.
Another top story was about behavioral weight-management programs. Data showed that losing weight within the first month of participating in these programs increased the odds for both short-term and long-term weight loss success.
Read these and more top stories in endocrinology below:
Number of hip fractures projected to nearly double worldwide by 2050
The total number of hip fractures globally is projected to nearly double from 2018 to 2050 as the aging population is expected to increase, according to a speaker at the American Society for Bone and Mineral Research Annual Meeting. Read more.
Early weight loss in behavioral weight-management programs predicts long-term success
Adults who lose weight in the first 4 weeks of a behavioral weight-management program are more likely to have successful medium-term weight loss, according to a speaker at the European Association for the Study of Diabetes annual meeting. Read more.
FDA warns of possible cybersecurity risk with Medtronic MiniMed 600 Series insulin pumps
The FDA has issued an alert warning people with diabetes using a Medtronic MiniMed 630G or MiniMed 670G insulin pump of a possible cybersecurity risk, according to an agency press release. Read more.
Eating more yogurt, low-fat dairy may reduce risk for type 2 diabetes
Eating moderate amounts of dairy products could reduce one’s risk for developing type 2 diabetes, according to a speaker at the European Association for the Study of Diabetes annual meeting. Read more.
‘Don’t dismiss the patient’: Promises, pitfalls of at-home hormone testing
At-home medical testing, ranging from cancer screening to COVID-19 detection, may be transforming health care, but some direct-to-consumer hormone test kits have raised red flags for endocrinologists. Read more.